Prevention of Progression of Duodenal Adenomas to Cancer in Patients With Familial Adenomatous Polyposis (FAP).

Trial Profile

Prevention of Progression of Duodenal Adenomas to Cancer in Patients With Familial Adenomatous Polyposis (FAP).

Completed
Phase of Trial: Phase II/III

Latest Information Update: 10 May 2013

At a glance

  • Drugs Celecoxib (Primary) ; Ursodeoxycholic acid (Primary)
  • Indications Intestinal cancer
  • Focus Therapeutic Use
  • Acronyms PreDuoFAP
  • Most Recent Events

    • 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 May 2011 Planned end date changed from 1 Sep 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.
    • 05 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top